Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 4:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (100.0%)Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
Phase 4
Completed
- Conditions
- Varicella
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2014-09-01
- Lead Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Target Recruit Count
- 716
- Registration Number
- NCT02173899
- Locations
- 🇨🇳
Shenzhen Luohu District Center for Disease Control and Prevention, Shenzhen, Guangdong, China
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
Phase 4
Completed
- Conditions
- Chickenpox
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Target Recruit Count
- 368
- Registration Number
- NCT01817270
- Locations
- 🇨🇳
Xinxing Center for Disease Control and Prevention, Yunfu, Guangdong, China
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
Phase 4
Completed
- Conditions
- Japanese EncephalitisChickenpox
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2014-02-24
- Lead Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Target Recruit Count
- 497
- Registration Number
- NCT01815073
- Locations
- 🇨🇳
Guangzhou Haizhu District Center for Disease Control and Prevention, Guangzhou, Guangdong, China
News
No news found